AOAC Method SMPR 2016.009 Instrumentation Guide

Standard Method Performance Requirements (SMPRs) for DNA-Based Methods of Detecting Brucella suis in Field-Deployable, Department of Defense Aerosol Collection Devices

AOAC SMPR 2016.009 outlines critical criteria for DNA-based detection of Brucella suis in buffer and environmental aerosol matrices using field-deployable technologies. The method establishes an Acceptable Minimum Detection Level (AMDL) of 2,000 genomic equivalents per milliliter for B. suis biovar 1, type strain 1330, with a minimum Probability of Detection (POD) of 0.95. Systems must produce results within four hours and maintain false-positive and false-negative rates of no more than 5%. Inclusivity testing is required at 2× AMDL across all B. suis biovars, and exclusivity testing at 10× AMDL against non-target strains must yield negative results.

A photo of APPLIED BIOSYSTEMS Real-Time PCR System for AOAC Method SMPR 2016.009 that links to a catalog of Real-Time qPCR equipment.

Instrument platforms must be capable of operating under field conditions, support rapid molecular workflows, and integrate internal controls to verify assay integrity. Suitable platforms include handheld or mobile-lab-compatible PCR systems and isothermal devices that allow for quick and accurate pathogen identification. The instruments listed below meet these requirements when used with appropriately validated assays. Laboratories and DoD field teams can use this guide to identify systems that fulfill SMPR compliance expectations in high-risk deployment settings.

Please click here to learn more about AOAC Method SMPR 2016.009

Applied Biosystems ABI 7500 Fast DX Real-Time PCR System for AOAC Method SMPR 2016.009

The Applied Biosystems ABI 7500 Fast DX Real-Time PCR System offers high analytical sensitivity and well-established reliability in public health and biodefense testing. This system supports real-time qPCR protocols that, with validated assays, meet the SMPR’s AMDL of 2,000 genomic equivalents/mL and POD ≥ 0.95. The 96-well format allows for moderate-throughput screening, while its stable thermal performance ensures consistent results across multiple replicates. When deployed in mobile laboratories or container-based labs, it offers a strong foundation for confirmatory analysis.

Although not a handheld device, this platform is often used in DoD-deployed trailers or mobile biosurveillance units. When configured with internal control assays, it meets inclusivity and exclusivity testing requirements across a wide array of matrices. Its compatibility with FDA-cleared assays also allows for easier assay validation in regulated settings. Laboratories must ensure that assay development and validation include matrix testing at 2× and 10× AMDL to confirm full method compliance. The ABI 7500 Fast DX remains a proven platform for operational response teams requiring scalable throughput.

T-COR 8 Real-Time PCR/Isothermal Device (Tetracore) for AOAC Method SMPR 2016.009

Tetracore’s T-COR 8 system is a ruggedized, battery-operated platform that supports both qPCR and isothermal amplification. Designed specifically for field use, this compact system delivers rapid detection in under one hour, well within the SMPR’s four-hour time requirement. With eight reaction wells and a closed cartridge format, the T-COR 8 enables multi-target screening with minimal sample handling. It’s ideal for first responders and military units that require quick, on-site confirmation of biological threats in aerosol matrices.

When paired with a validated assay, the T-COR 8 meets or exceeds the AMDL and POD thresholds outlined in SMPR 2016.009. Validation protocols must also verify inclusivity across all B. suis biovars and demonstrate exclusivity against other Brucella and near-neighbor organisms at elevated concentrations. Its portability, short learning curve, and consistent performance make it one of the best options for austere environments. It supports both investigational and emergency response testing workflows, and is a strong candidate for tactical field use.

BioFire® FilmArray® Torch (with Military Panels) for AOAC Method SMPR 2016.009

The BioFire FilmArray Torch System offers streamlined molecular testing with integrated sample preparation, amplification, and analysis. Its military-use biothreat panel includes validated targets like Brucella suis, enabling comprehensive surveillance with minimal operator input. The system delivers accurate results in less than an hour and meets the AOAC SMPR requirement for maximum time-to-result. Internal controls embedded in the panel pouch verify test validity for each sample and ensure automated quality assurance.

Although designed for use in mobile laboratories or fixed locations, the FilmArray Torch significantly reduces hands-on time and training requirements. Its ability to detect B. suis with preconfigured, validated pouches simplifies compliance with AMDL and POD performance thresholds. To fulfill the inclusivity and exclusivity mandates, military panels must undergo matrix testing at appropriate concentration multiples. This platform is particularly advantageous in high-volume, high-risk environments where operator error must be minimized.

Genie® III or Genie® HT Isothermal Systems (OptiGene) for AOAC Method SMPR 2016.009

The Genie III and Genie HT systems from OptiGene provide portable, battery-powered detection using loop-mediated isothermal amplification (LAMP). Their rapid detection capability, delivering results in less than 30 minutes, makes them highly suitable for time-sensitive deployments. These devices are compact and easy to operate, requiring minimal training while maintaining high analytical sensitivity and specificity. They are ideal for low-resource environments and frontline biothreat screening missions that demand quick, reliable data.

Assays developed on Genie platforms must be validated against AOAC SMPR 2016.009’s criteria, including AMDL, POD, and strain-based inclusivity and exclusivity. Validation should include testing with B. suis biovar 1 at 2× AMDL and non-targets at 10× AMDL to verify compliance. The Genie systems support both visual and digital result interpretation, and their field portability offers unmatched flexibility. For tactical teams and rapid response units, Genie platforms provide an optimal mix of accuracy, speed, and operational simplicity.

BioRad CFX Opus Deep Well Real-Time PCR System (with mobile lab integration) for AOAC Method SMPR 2016.009

The BioRad CFX Opus Deep Well Real-Time PCR System delivers high-throughput detection with robust precision, making it ideal for confirmatory testing in semi-fixed or mobile laboratory settings. Its flexible software suite, thermal stability, and high-capacity well design support efficient field operations. The system supports complex multiplex PCR assays that can target B. suis and multiple controls in a single run. With validated assays, it comfortably meets the SMPR’s required AMDL and time-to-result metrics.

To meet full compliance with AOAC SMPR 2016.009, validation procedures must assess assay performance at 2× and 10× AMDL across both clean and environmental matrices. The CFX Opus system also enables users to track inclusivity and exclusivity test data across operational deployments. Though not handheld, its integration into containerized mobile labs makes it a trusted platform for rapid, large-scale response. Labs prioritizing traceability, scalability, and detailed performance monitoring often deploy this system in national emergency preparedness networks.

Cepheid GeneXpert Omni (limited release) for AOAC Method SMPR 2016.009

The Cepheid GeneXpert Omni is a portable, battery-powered molecular diagnostic system designed for remote and forward-operating environments. It uses self-contained cartridges that automate sample preparation, nucleic acid extraction, amplification, and detection in a fully closed system. With less than an hour to result, the Omni system is aligned with the SMPR 2016.009 requirement for rapid detection. Minimal user training is required, and internal assay controls provide built-in assurance of test validity and reproducibility.

Validated Brucella suis assays for the GeneXpert Omni must meet the AMDL of 2,000 genomic equivalents/mL and demonstrate a POD of ≥0.95 in field matrix conditions. To ensure compliance, inclusivity testing must confirm detection across all B. suis biovars at 2× AMDL, while exclusivity testing must show no cross-reactivity at 10× AMDL. Its rugged form factor and user-friendly interface make it ideal for military applications where speed and dependability are critical. The Omni system stands out for its automation and closed design, which help prevent contamination during mission-critical operations.

Choosing the Right Instrument for AOAC Method SMPR 2016.009

  • Validated field solutions: T-COR 8, GeneXpert Omni, Genie III, and FilmArray Torch enable low-maintenance testing with rapid time-to-result.
  • Mobile lab integration: ABI 7500 Fast DX and BioRad CFX Opus offer reliable performance for confirmatory workflows in mobile environments.
  • Assay validation essential: All platforms must confirm AMDL compliance (2,000 GE/mL), POD ≥ 0.95, and meet inclusivity and exclusivity thresholds.

Ensure your laboratory or field team is equipped to meet AOAC SMPR 2016.009 standards by selecting instruments that support validated assays for Brucella suis biovar 1 detection at or below the AMDL of 2,000 genomic equivalents/mL. Your system must deliver ≥95% POD, results within four hours, and pass all inclusivity and exclusivity testing in real-world matrices. The platforms featured in this guide provide proven capabilities to meet these benchmarks. When paired with the right assay, they deliver field-ready accuracy and speed. Contact us today to explore certified refurbished instruments configured for SMPR 2016.009 compliance and mission-critical biosurveillance.